Healthcare Sector Stocks
The Healthcare sector has a total of 1048 stocks, with a combined market cap of $9.86 trillion, total revenue of $4.74 trillion and a weighted average PE ratio of 46.30.
Market Cap
9.86T
Revenue
4.74T
Profits
212.98B
PE Ratio
46.30
Profit Margin
4.50%
Dividend Yield
0.38%
1047 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.26T | -1.13% | 2,649,265 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 670.92B | -1.36% | 8,979,245 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 517.59B | -0.59% | 3,950,015 | 66.01B |
| 4 | MRK | Merck & Co., Inc. | 353.44B | -0.75% | 7,270,183 | 67.38B |
| 5 | UNH | UnitedHealth Group Incorporated | 349.16B | -5.42% | 8,048,976 | 450.06B |
| 6 | NVS | Novartis AG | 300.17B | -0.67% | 1,464,456 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 282.97B | -0.95% | 2,369,608 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 254.47B | -0.66% | 1,583,767 | 47.35B |
| 9 | AMGN | Amgen Inc. | 247.70B | -0.95% | 2,034,924 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 211.18B | 1.60% | 6,284,408 | 30.99B |
| 11 | ABT | Abbott Laboratories | 181.35B | -2.55% | 5,924,133 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 178.97B | -2.16% | 17,838,963 | 50.70B |
| 13 | PFE | Pfizer Inc. | 162.27B | -1.35% | 35,356,547 | 63.62B |
| 14 | DHR | Danaher Corporation | 158.84B | -1.80% | 3,561,888 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 149.24B | -1.65% | 2,527,783 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 135.44B | -0.67% | 1,512,600 | 12.95B |
| 17 | MCK | McKesson Corporation | 126.04B | -1.21% | 722,819 | 418.79B |
| 18 | BMY | Bristol-Myers Squibb Company | 125.40B | -2.51% | 14,650,246 | 50.03B |
| 19 | MDT | Medtronic plc | 125.25B | -0.54% | 5,347,339 | 37.54B |
| 20 | SYK | Stryker Corporation | 120.88B | 2.19% | 4,570,655 | 26.30B |
| 21 | SNY | Sanofi | 114.24B | -1.78% | 1,765,317 | 57.89B |
| 22 | CVS | CVS Health Corporation | 109.79B | -3.14% | 13,620,793 | 418.16B |
| 23 | HCA | HCA Healthcare, Inc. | 104.69B | -2.07% | 1,244,275 | 78.70B |
| 24 | GSK | GSK plc | 99.04B | -2.32% | 2,950,332 | 44.53B |
| 25 | REGN | Regeneron Pharmaceuticals, Inc. | 96.11B | 0.56% | 933,408 | 16.90B |
| 26 | ELV | Elevance Health, Inc. | 93.75B | -2.77% | 1,175,014 | 201.83B |
| 27 | MRNA | Moderna, Inc. | 83.68B | -3.93% | 8,277,037 | 2.53B |
| 28 | CI | The Cigna Group | 77.49B | -2.03% | 1,534,433 | 286.32B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 68.89B | 0.23% | 3,375,466 | 29.86B |
| 30 | COR | Cencora, Inc. | 66.90B | -1.79% | 1,349,594 | 337.40B |
| 31 | CAH | Cardinal Health, Inc. | 64.54B | -1.62% | 1,851,205 | 257.75B |
| 32 | BSX | Boston Scientific Corporation | 62.37B | -1.51% | 12,914,598 | 21.07B |
| 33 | EW | Edwards Lifesciences Corporation | 60.62B | -1.57% | 4,272,484 | 6.67B |
| 34 | ARGX | argenx SE | 58.86B | -0.36% | 418,656 | 5.92B |
| 35 | BDX | Becton, Dickinson and Company | 58.68B | -0.49% | 2,307,415 | 19.46B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 54.38B | -1.49% | 400,850 | 4.66B |
| 37 | HUM | Humana Inc. | 53.25B | -3.88% | 1,888,556 | 154.19B |
| 38 | TEVA | Teva Pharmaceutical Industries Limited | 49.73B | 0.12% | 7,019,571 | 17.23B |
| 39 | MDLN | Medline Inc. | 49.56B | -3.80% | 9,076,137 | 30.68B |
| 40 | A | Agilent Technologies, Inc. | 48.55B | -0.40% | 2,465,307 | 7.37B |
| 41 | ONC | BeOne Medicines AG | 47.21B | 0.48% | 235,012 | 6.45B |
| 42 | VEEV | Veeva Systems Inc. | 46.70B | -3.63% | 1,239,088 | 3.46B |
| 43 | WAT | Waters Corporation | 44.21B | -0.80% | 585,019 | 5.61B |
| 44 | IQV | IQVIA Holdings Inc. | 42.45B | -2.69% | 1,728,524 | 17.31B |
| 45 | NTRA | Natera, Inc. | 41.68B | -0.35% | 2,246,957 | 2.91B |
| 46 | HLN | Haleon plc | 39.78B | -1.63% | 11,882,273 | 14.80B |
| 47 | RPRX | Royalty Pharma plc | 39.40B | 0.22% | 2,803,263 | 2.62B |
| 48 | BIIB | Biogen Inc. | 37.07B | -0.34% | 969,020 | 10.30B |
| 49 | GEHC | GE HealthCare Technologies Inc. | 37.00B | -1.35% | 2,920,732 | 21.64B |
| 50 | CNC | Centene Corporation | 35.92B | -2.97% | 6,022,079 | 180.41B |
| 51 | ALC | Alcon Inc. | 35.40B | 0.64% | 4,795,654 | 10.98B |
| 52 | RVMD | Revolution Medicines, Inc. | 35.19B | -2.50% | 2,690,017 | 197.56M |
| 53 | MTD | Mettler-Toledo International Inc. | 34.07B | -0.83% | 130,014 | 4.20B |
| 54 | ZTS | Zoetis Inc. | 33.92B | -1.08% | 3,397,436 | 9.49B |
| 55 | RMD | ResMed Inc. | 33.46B | -0.14% | 1,478,750 | 5.73B |
| 56 | GMAB | Genmab A/S | 32.66B | 0.76% | 3,322,454 | 4.30B |
| 57 | ILMN | Illumina, Inc. | 30.63B | 2.33% | 1,671,595 | 4.54B |
| 58 | DXCM | DexCom, Inc. | 30.60B | 0.53% | 4,583,979 | 5.10B |
| 59 | LH | Labcorp Holdings Inc. | 29.90B | -1.13% | 715,288 | 14.59B |
| 60 | PHG | Koninklijke Philips N.V. | 29.25B | -0.83% | 930,715 | 20.16B |
| 61 | WST | West Pharmaceutical Services, Inc. | 28.85B | -0.88% | 494,113 | 3.40B |
| 62 | DGX | Quest Diagnostics Incorporated | 28.20B | -2.23% | 936,286 | 11.84B |
| 63 | ROIV | Roivant Sciences Ltd. | 28.05B | 0.26% | 8,472,732 | 41.08M |
| 64 | INSM | Insmed Incorporated | 26.73B | -0.83% | 2,398,022 | 1.52B |
| 65 | STE | STERIS plc | 25.00B | -1.46% | 876,106 | 6.17B |
| 66 | UTHR | United Therapeutics Corporation | 24.88B | -0.64% | 424,480 | 3.19B |
| 67 | INCY | Incyte Corporation | 24.27B | -0.98% | 2,247,063 | 6.01B |
| 68 | VTRS | Viatris Inc. | 23.44B | -1.40% | 10,384,304 | 14.73B |
| 69 | THC | Tenet Healthcare Corporation | 22.45B | -3.25% | 626,597 | 22.15B |
| 70 | BNTX | BioNTech SE | 21.04B | -0.47% | 1,105,075 | 2.75B |
| 71 | ALNY | Alnylam Pharmaceuticals, Inc. | 20.96B | -2.02% | 2,050,016 | 5.01B |
| 72 | GH | Guardant Health, Inc. | 19.38B | -0.52% | 1,960,205 | 1.28B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 19.32B | 0.67% | 3,361,317 | 8.57B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.27B | 0.75% | 180,226 | 2.84B |
| 75 | ASND | Ascendis Pharma A/S | 17.79B | -0.20% | 586,833 | 1.37B |
| 76 | NBIX | Neurocrine Biosciences, Inc. | 16.79B | 0.37% | 1,142,354 | 3.70B |
| 77 | EXEL | Exelixis, Inc. | 16.71B | 2.09% | 2,818,825 | 2.50B |
| 78 | RVTY | Revvity, Inc. | 16.50B | -0.71% | 1,511,565 | 2.94B |
| 79 | CRL | Charles River Laboratories International, Inc. | 15.92B | -1.00% | 697,548 | 3.98B |
| 80 | JAZZ | Jazz Pharmaceuticals plc | 15.45B | 0.39% | 499,524 | 4.72B |
| 81 | BBIO | BridgeBio Pharma, Inc. | 14.96B | -0.72% | 2,812,209 | 945.54M |
| 82 | ICLR | ICON Public Limited Company | 14.61B | 1.89% | 662,790 | 8.23B |
| 83 | SOLV | Solventum Corporation | 14.61B | -2.92% | 725,363 | 8.16B |
| 84 | BTSG | BrightSpring Health Services, Inc. | 14.55B | -2.16% | 2,121,348 | 15.25B |
| 85 | GKOS | Glaukos Corporation | 14.39B | -0.67% | 718,403 | 690.33M |
| 86 | EHC | Encompass Health Corporation | 13.53B | -2.98% | 917,898 | 6.34B |
| 87 | BAX | Baxter International Inc. | 13.33B | 0.86% | 4,165,062 | 11.61B |
| 88 | ELAN | Elanco Animal Health Incorporated | 12.92B | -2.12% | 3,844,429 | 5.15B |
| 89 | SNN | Smith & Nephew plc | 12.75B | -1.49% | 1,411,959 | 6.30B |
| 90 | PEN | Penumbra, Inc. | 12.58B | -0.47% | 365,985 | 1.56B |
| 91 | RDY | Dr. Reddy's Laboratories Limited | 12.37B | 0.61% | 1,517,196 | 3.44B |
| 92 | TEM | Tempus AI, Inc. | 11.57B | -2.05% | 6,207,780 | 1.51B |
| 93 | COO | The Cooper Companies, Inc. | 11.55B | -1.87% | 1,776,684 | 4.24B |
| 94 | MOH | Molina Healthcare, Inc. | 11.52B | -5.10% | 968,730 | 42.08B |
| 95 | ALGN | Align Technology, Inc. | 11.52B | -1.52% | 1,079,270 | 4.16B |
| 96 | TECH | Bio-Techne Corporation | 11.41B | -0.22% | 5,694,156 | 1.23B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 11.33B | 0.90% | 2,252,160 | 3.66B |
| 98 | FMS | Fresenius Medical Care AG | 11.26B | -0.78% | 873,051 | 22.12B |
| 99 | UHS | Universal Health Services, Inc. | 11.07B | -2.94% | 581,804 | 18.35B |
| 100 | HALO | Halozyme Therapeutics, Inc. | 10.94B | -0.55% | 2,041,121 | 1.80B |
| 101 | DVA | DaVita Inc. | 10.89B | -0.70% | 459,953 | 14.17B |
| 102 | ENSG | The Ensign Group, Inc. | 10.76B | -1.17% | 244,781 | 5.67B |
| 103 | MTRI | Mentari Therapeutics, Inc. | 10.52B | -11.93% | 171,052 | - |
| 104 | KYMR | Kymera Therapeutics, Inc. | 10.37B | -3.44% | 855,182 | 102.24M |
| 105 | RGEN | Repligen Corporation | 10.37B | -0.37% | 770,860 | 805.61M |
| 106 | AVTR | Avantor, Inc. | 10.29B | -0.91% | 5,932,083 | 6.64B |
| 107 | QGEN | Qiagen N.V. | 10.27B | -0.12% | 2,205,837 | 2.12B |
| 108 | PODD | Insulet Corporation | 10.08B | 0.03% | 1,401,488 | 3.19B |
| 109 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.80B | -0.46% | 364,692 | 1.43B |
| 110 | BIO | Bio-Rad Laboratories, Inc. | 9.63B | -0.57% | 202,631 | 2.59B |
| 111 | PCVX | Vaxcyte, Inc. | 9.40B | -3.59% | 1,107,709 | - |
| 112 | BRKR | Bruker Corporation | 9.37B | 1.22% | 1,875,332 | 3.51B |
| 113 | HNGE | Hinge Health, Inc. | 9.30B | -5.67% | 1,744,754 | 800.82M |
| 114 | GMED | Globus Medical, Inc. | 9.27B | -0.72% | 1,140,848 | 3.14B |
| 115 | OSCR | Oscar Health, Inc. | 9.26B | -4.76% | 4,225,182 | 17.47B |
| 116 | HSIC | Henry Schein, Inc. | 9.17B | -2.38% | 1,517,858 | 13.73B |
| 117 | SYRE | Spyre Therapeutics, Inc. | 8.91B | -5.60% | 1,109,264 | - |
| 118 | ATR | AptarGroup, Inc. | 8.90B | -1.98% | 430,610 | 3.99B |
| 119 | KRYS | Krystal Biotech, Inc. | 8.85B | 0.22% | 164,446 | 470.03M |
| 120 | TGTX | TG Therapeutics, Inc. | 8.79B | -0.08% | 1,714,276 | 897.76M |
| 121 | SMMT | Summit Therapeutics Inc. | 8.53B | -9.73% | 13,171,552 | - |
| 122 | PRAX | Praxis Precision Medicines, Inc. | 8.53B | -1.68% | 836,928 | 7.46M |
| 123 | HQY | HealthEquity, Inc. | 8.42B | -2.62% | 600,507 | 1.36B |
| 124 | PTGX | Protagonist Therapeutics, Inc. | 8.14B | -0.13% | 583,078 | 551.69M |
| 125 | RYTM | Rhythm Pharmaceuticals, Inc. | 8.08B | 8.49% | 2,597,243 | 280.75M |
| 126 | PACS | PACS Group, Inc. | 7.71B | -0.92% | 484,314 | 5.71B |
| 127 | CORT | Corcept Therapeutics Incorporated | 7.67B | 1.23% | 985,579 | 963.65M |
| 128 | ALKS | Alkermes plc | 7.64B | -2.32% | 932,618 | 1.75B |
| 129 | GRFS | Grifols, S.A. | 7.61B | -1.15% | 624,696 | 8.63B |
| 130 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.47B | 0.93% | 387,943 | 945.96M |
| 131 | BLCO | Bausch + Lomb Corporation | 7.45B | -0.24% | 582,087 | 5.42B |
| 132 | TXG | 10x Genomics, Inc. | 7.41B | 2.38% | 2,866,337 | 618.58M |
| 133 | AMRX | Amneal Pharmaceuticals, Inc. | 7.36B | -0.52% | 2,327,432 | 3.20B |
| 134 | ABVX | ABIVAX Société Anonyme | 7.25B | -1.81% | 1,375,464 | 5.33M |
| 135 | CYTK | Cytokinetics, Incorporated | 7.20B | -2.86% | 2,712,186 | 113.29M |
| 136 | AXSM | Axsome Therapeutics, Inc. | 7.15B | -0.77% | 518,787 | 865.27M |
| 137 | CHE | Chemed Corporation | 7.09B | -0.49% | 147,561 | 2.66B |
| 138 | CGON | CG Oncology, Inc. | 7.05B | -6.89% | 3,161,183 | 6.17M |
| 139 | TWST | Twist Bioscience Corporation | 7.02B | 6.63% | 2,070,077 | 459.43M |
| 140 | IMVT | Immunovant, Inc. | 6.87B | -0.21% | 926,731 | - |
| 141 | IBRX | ImmunityBio, Inc. | 6.66B | 4.68% | 11,508,019 | 182.57M |
| 142 | LNTH | Lantheus Holdings, Inc. | 6.66B | 0.08% | 679,896 | 1.56B |
| 143 | ORKA | Oruka Therapeutics, Inc. | 6.53B | -2.94% | 780,187 | - |
| 144 | BLTE | Belite Bio, Inc | 6.35B | -2.98% | 94,842 | - |
| 145 | TFX | Teleflex Incorporated | 6.33B | 1.56% | 1,588,851 | 2.26B |
| 146 | KOD | Kodiak Sciences Inc. | 6.32B | -3.90% | 820,887 | - |
| 147 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.08B | -2.76% | 3,703,616 | 450.82M |
| 148 | SUPN | Supernus, Inc. | 6.03B | 0.73% | 2,810,125 | 1.37B |
| 149 | MIRM | Mirum Pharmaceuticals, Inc. | 6.00B | 0.40% | 377,669 | 670.78M |
| 150 | RDNT | RadNet, Inc. | 5.90B | -2.56% | 393,616 | 2.38B |
| 151 | LGND | Ligand Pharmaceuticals Incorporated | 5.88B | -2.62% | 293,656 | 253.83M |
| 152 | CAI | Caris Life Sciences, Inc. | 5.72B | -5.05% | 4,901,076 | 1.05B |
| 153 | DOCS | Doximity, Inc. | 5.55B | -5.07% | 2,763,700 | 661.58M |
| 154 | HAE | Haemonetics Corporation | 5.51B | -0.35% | 855,432 | 1.38B |
| 155 | SRRK | Scholar Rock Holding Corporation | 5.50B | 1.21% | 2,330,646 | 570.00K |
| 156 | LFST | LifeStance Health Group, Inc. | 5.39B | -2.14% | 6,324,844 | 1.68B |
| 157 | CON | Concentra Group Holdings Parent, Inc. | 5.36B | -2.44% | 680,839 | 2.34B |
| 158 | WAY | Waystar Holding Corp. | 5.32B | -1.57% | 2,959,437 | 1.26B |
| 159 | MANE | Veradermics, Incorporated | 5.30B | -1.88% | 401,328 | - |
| 160 | LQDA | Liquidia Corporation | 5.11B | 0.64% | 1,912,074 | 621.87M |
| 161 | LIVN | LivaNova PLC | 5.06B | -0.56% | 573,618 | 1.51B |
| 162 | MMSI | Merit Medical Systems, Inc. | 5.06B | -2.15% | 630,481 | 1.61B |
| 163 | PTCT | PTC Therapeutics, Inc. | 5.04B | -1.00% | 1,122,336 | 1.16B |
| 164 | MMED | MiniMed Group, Inc. | 5.00B | -4.66% | 5,027,276 | 3.22B |
| 165 | TVTX | Travere Therapeutics, Inc. | 4.91B | 2.82% | 1,399,276 | 651.03M |
| 166 | DNTH | Dianthus Therapeutics, Inc. | 4.90B | -2.87% | 563,973 | 2.72M |
| 167 | ERAS | Erasca, Inc. | 4.87B | -8.07% | 8,792,394 | - |
| 168 | COGT | Cogent Biosciences, Inc. | 4.85B | 1.49% | 3,363,431 | - |
| 169 | GRAL | GRAIL, Inc. | 4.76B | 0.27% | 701,006 | 166.60M |
| 170 | OPCH | Option Care Health, Inc. | 4.74B | -0.25% | 3,577,573 | 5.75B |
| 171 | BLLN | BillionToOne, Inc. | 4.66B | 1.24% | 778,824 | 436.87M |
| 172 | ADPT | Adaptive Biotechnologies Corporation | 4.61B | 2.22% | 1,938,192 | 298.01M |
| 173 | EWTX | Edgewise Therapeutics, Inc. | 4.60B | -3.75% | 1,401,221 | - |
| 174 | SHC | Sotera Health Company | 4.58B | -1.23% | 2,611,728 | 1.23B |
| 175 | IONS | Ionis Pharmaceuticals, Inc. | 4.49B | -3.75% | 4,485,275 | 960.09M |
| 176 | ICUI | ICU Medical, Inc. | 4.42B | -2.73% | 289,388 | 2.18B |
| 177 | STVN | Stevanato Group S.p.A. | 4.17B | -1.80% | 813,319 | 1.42B |
| 178 | HTFL | HeartFlow, Inc. | 4.14B | 0.45% | 1,369,028 | 238.66M |
| 179 | HIMS | Hims & Hers Health, Inc. | 4.11B | -5.44% | 13,236,394 | 2.87B |
| 180 | DFTX | Definium Therapeutics, Inc. | 4.02B | -2.59% | 1,937,178 | - |
| 181 | CDNA | CareDx, Inc. | 3.92B | 1.14% | 815,182 | 497.40M |
| 182 | SLS | SELLAS Life Sciences Group, Inc. | 3.90B | 156.36% | 120,290,299 | - |
| 183 | CRSP | CRISPR Therapeutics AG | 3.89B | -0.54% | 4,109,690 | 25.17M |
| 184 | TARS | Tarsus Pharmaceuticals, Inc. | 3.86B | -0.61% | 542,221 | 682.20M |
| 185 | XENE | Xenon Pharmaceuticals Inc. | 3.81B | -1.22% | 2,396,354 | 7.50M |
| 186 | NVST | Envista Holdings Corporation | 3.80B | -1.37% | 2,990,483 | 2.88B |
| 187 | TNGX | Tango Therapeutics, Inc. | 3.75B | -8.52% | 2,058,210 | 53.81M |
| 188 | OGN | Organon & Co. | 3.65B | 0.00% | 4,163,652 | 6.10B |
| 189 | RLAY | Relay Therapeutics, Inc. | 3.64B | -4.63% | 2,569,232 | 10.35M |
| 190 | ABCL | AbCellera Biologics Inc. | 3.60B | -0.81% | 2,695,688 | 67.85M |
| 191 | PBLS | Parabilis Medicines, Inc. | 3.54B | -0.70% | 480,478 | 2.26M |
| 192 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.54B | -1.01% | 1,175,965 | -665.00K |
| 193 | ACHC | Acadia Healthcare Company, Inc. | 3.53B | -1.96% | 2,172,727 | 3.41B |
| 194 | IRON | Disc Medicine, Inc. | 3.49B | -0.03% | 520,625 | - |
| 195 | IOVA | Iovance Biotherapeutics, Inc. | 3.48B | -0.26% | 8,842,942 | 378.98M |
| 196 | SGRY | Surgery Partners, Inc. | 3.48B | 0.22% | 2,034,140 | 3.36B |
| 197 | ARQT | Arcutis Biotherapeutics, Inc. | 3.46B | 0.66% | 1,315,543 | 508.68M |
| 198 | ELVN | Enliven Therapeutics, Inc. | 3.45B | -1.62% | 652,272 | - |
| 199 | VKTX | Viking Therapeutics, Inc. | 3.43B | 0.30% | 4,577,484 | - |
| 200 | VRDN | Viridian Therapeutics, Inc. | 3.41B | 0.87% | 1,812,270 | 26.31M |
| 201 | AXGN | Axogen, Inc. | 3.31B | -0.02% | 1,352,564 | 266.93M |
| 202 | PLSE | Pulse Biosciences, Inc. | 3.30B | -3.28% | 628,540 | 1.49M |
| 203 | TMDX | TransMedics Group, Inc. | 3.26B | 1.84% | 960,725 | 727.65M |
| 204 | NHC | National HealthCare Corporation | 3.22B | -0.69% | 90,265 | 1.58B |
| 205 | WRBY | Warby Parker Inc. | 3.22B | -1.18% | 4,282,159 | 934.66M |
| 206 | PRVA | Privia Health Group, Inc. | 3.19B | -1.07% | 1,099,950 | 2.43B |
| 207 | GRDN | Guardian Pharmacy Services, Inc. | 3.19B | 1.82% | 333,495 | 1.46B |
| 208 | BHC | Bausch Health Companies Inc. | 3.17B | 0.59% | 2,702,689 | 11.11B |
| 209 | ACAD | Acadia Pharmaceuticals Inc. | 3.17B | -1.87% | 1,535,422 | 1.20B |
| 210 | LEGN | Legend Biotech Corporation | 3.12B | 0.75% | 3,030,025 | 1.36B |
| 211 | XERS | Xeris Biopharma Holdings, Inc. | 3.07B | 0.60% | 2,659,294 | 368.26M |
| 212 | TLX | Telix Pharmaceuticals Limited | 3.05B | -0.73% | 249,302 | 890.79M |
| 213 | ADMA | ADMA Biologics, Inc. | 3.02B | 1.19% | 2,948,327 | 519.15M |
| 214 | IRTC | iRhythm Holdings, Inc. | 3.01B | -1.28% | 590,216 | 854.04M |
| 215 | DYN | Dyne Therapeutics, Inc. | 3.00B | -4.07% | 2,058,016 | - |
| 216 | VCEL | Vericel Corporation | 2.95B | 0.70% | 555,309 | 324.17M |
| 217 | DNLI | Denali Therapeutics Inc. | 2.89B | -0.44% | 1,131,004 | 21.38M |
| 218 | CELC | Celcuity Inc. | 2.85B | -4.23% | 2,544,065 | - |
| 219 | ATRC | AtriCure, Inc. | 2.80B | -0.52% | 663,592 | 589.80M |
| 220 | PGNY | Progyny, Inc. | 2.70B | -1.18% | 909,210 | 1.34B |
| 221 | IDYA | IDEAYA Biosciences, Inc. | 2.65B | -9.75% | 2,044,684 | 36.54M |
| 222 | ZLAB | Zai Lab Limited | 2.65B | 0.26% | 690,593 | 441.73M |
| 223 | MBX | MBX Biosciences, Inc. | 2.64B | -0.04% | 356,069 | - |
| 224 | XNCR | Xencor, Inc. | 2.59B | -2.54% | 1,616,923 | 200.49M |
| 225 | HCM | HUTCHMED (China) Limited | 2.57B | -2.24% | 42,313 | 549.12M |
| 226 | AVAH | Aveanna Healthcare Holdings Inc. | 2.54B | 0.17% | 3,402,907 | 2.68B |
| 227 | CLOV | Clover Health Investments, Corp. | 2.53B | -4.44% | 4,138,238 | 2.74B |
| 228 | ARDT | Ardent Health, Inc. | 2.50B | -1.93% | 481,274 | 6.45B |
| 229 | NEOG | Neogen Corporation | 2.38B | 0.18% | 2,758,300 | 884.00M |
| 230 | MD | Pediatrix Medical Group, Inc. | 2.37B | -2.38% | 428,572 | 1.96B |
| 231 | RCUS | Arcus Biosciences, Inc. | 2.36B | -2.79% | 1,919,157 | 100.00M |
| 232 | NAMS | NewAmsterdam Pharma Company N.V. | 2.33B | -0.36% | 1,364,420 | 25.94M |
| 233 | UFPT | UFP Technologies, Inc. | 2.30B | -0.35% | 90,110 | 649.52M |
| 234 | PBH | Prestige Consumer Healthcare Inc. | 2.29B | 0.46% | 597,841 | 1.17B |
| 235 | PHVS | Pharvaris N.V. | 2.29B | -0.49% | 241,404 | - |
| 236 | RGC | Regencell Bioscience Holdings Limited | 2.26B | -3.60% | 95,264 | - |
| 237 | ADUS | Addus HomeCare Corporation | 2.22B | -2.45% | 124,650 | 1.50B |
| 238 | LKFT | Lakefront Biotherapeutics NV | 2.22B | -1.15% | 241,179 | 1.13B |
| 239 | CLDX | Celldex Therapeutics, Inc. | 2.20B | -1.92% | 520,652 | 158.00K |
| 240 | PRGO | Perrigo Company plc | 2.19B | -2.60% | 1,719,690 | 4.09B |
| 241 | ALMR | Alamar Biosciences, Inc. | 2.13B | 0.29% | 466,677 | 114.05M |
| 242 | PVLA | Palvella Therapeutics, Inc. | 2.11B | -0.17% | 212,094 | - |
| 243 | BKD | Brookdale Senior Living Inc. | 2.11B | -1.79% | 14,763,516 | 2.86B |
| 244 | ESTA | Establishment Labs Holdings Inc. | 2.07B | -0.44% | 369,405 | 264.03M |
| 245 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | -0.52% | 833,659 | 321.74M |
| 246 | BEAM | Beam Therapeutics Inc. | 2.06B | -1.38% | 4,127,713 | 146.64M |
| 247 | IMNM | Immunome, Inc. | 2.03B | -2.44% | 1,027,500 | 4.02M |
| 248 | BHVN | Biohaven Ltd. | 2.00B | -4.06% | 1,569,005 | - |
| 249 | NEO | NeoGenomics, Inc. | 1.97B | -1.04% | 1,033,367 | 787.75M |
| 250 | VCYT | Veracyte, Inc. | 1.96B | 0.92% | 3,056,165 | 581.78M |
| 251 | TRLV | Trulieve Cannabis Corp. | 1.94B | -2.52% | 1,492,265 | 1.08B |
| 252 | HRMY | Harmony Biosciences Holdings, Inc. | 1.94B | 0.15% | 607,335 | 989.36M |
| 253 | AGL | agilon health, inc. | 1.93B | -1.33% | 211,233 | 6.00B |
| 254 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.93B | 0.67% | 3,877,203 | 961.51M |
| 255 | SDGR | Schrödinger, Inc. | 1.93B | -6.21% | 1,195,150 | 269.20M |
| 256 | TRVI | Trevi Therapeutics, Inc. | 1.93B | 1.66% | 1,728,750 | - |
| 257 | AZTA | Azenta, Inc. | 1.91B | -2.99% | 1,412,194 | 621.70M |
| 258 | SEPN | Septerna, Inc. | 1.90B | -3.96% | 271,759 | 96.27M |
| 259 | VERA | Vera Therapeutics, Inc. | 1.89B | -2.86% | 1,222,088 | 10.28M |
| 260 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.89B | -1.62% | 1,609,062 | 213.00M |
| 261 | FTRE | Fortrea Holdings Inc. | 1.89B | -1.01% | 2,118,290 | 2.67B |
| 262 | ZBIO | Zenas BioPharma, Inc. | 1.88B | -0.64% | 524,657 | 11.00M |
| 263 | REPL | Replimune Group, Inc. | 1.87B | -8.03% | 2,434,492 | - |
| 264 | ETON | Eton Pharmaceuticals, Inc. | 1.84B | -0.36% | 578,908 | 141.06M |
| 265 | TRAX | First Tracks Biotherapeutics, Inc. | 1.83B | -6.42% | 586,582 | - |
| 266 | COAG | Hemab Therapeutics Holdings, Inc. | 1.83B | 0.00% | 281,496 | - |
| 267 | MAZE | Maze Therapeutics, Inc. | 1.80B | -3.04% | 601,754 | 20.00M |
| 268 | AGIO | Agios Pharmaceuticals, Inc. | 1.79B | -0.86% | 664,574 | 140.84M |
| 269 | ZYME | Zymeworks Inc. | 1.78B | -2.31% | 569,926 | 265.97M |
| 270 | LYCA | Lycia Therapeutics, Inc. | 1.78B | 8.07% | 496,271 | 4.44M |
| 271 | LMAT | LeMaitre Vascular, Inc. | 1.74B | -1.18% | 190,509 | 269.36M |
| 272 | STOK | Stoke Therapeutics, Inc. | 1.73B | -0.83% | 556,996 | 28.21M |
| 273 | INSP | Inspire Medical Systems, Inc. | 1.72B | 0.49% | 580,812 | 880.94M |
| 274 | XRAY | DENTSPLY SIRONA Inc. | 1.70B | -3.91% | 7,947,558 | 3.58B |
| 275 | RARE | Ultragenyx Pharmaceutical Inc. | 1.70B | 5.03% | 5,592,538 | 730.00M |
| 276 | RXRX | Recursion Pharmaceuticals, Inc. | 1.70B | -6.37% | 41,021,204 | 68.23M |
| 277 | CERT | Certara, Inc. | 1.69B | -2.90% | 2,283,349 | 425.76M |
| 278 | KMTS | Kestra Medical Technologies, Ltd. | 1.68B | 1.07% | 274,442 | 106.73M |
| 279 | HCSG | Healthcare Services Group, Inc. | 1.66B | -0.68% | 454,369 | 1.88B |
| 280 | ASTH | Astrana Health, Inc. | 1.64B | -2.68% | 324,142 | 3.91B |
| 281 | PSNL | Personalis, Inc. | 1.60B | 0.00% | 3,134,965 | 80.77M |
| 282 | ALHC | Alignment Healthcare, Inc. | 1.59B | 2.01% | 5,875,548 | 4.94B |
| 283 | VIR | Vir Biotechnology, Inc. | 1.58B | -3.44% | 3,483,985 | 302.80M |
| 284 | KLRA | Kailera Therapeutics, Inc. | 1.58B | -2.94% | 511,124 | - |
| 285 | SRPT | Sarepta Therapeutics, Inc. | 1.58B | -2.38% | 2,403,168 | 1.96B |
| 286 | SNDA | Sonida Senior Living, Inc. | 1.58B | -1.00% | 540,513 | 593.56M |
| 287 | MESO | Mesoblast Limited | 1.57B | -4.34% | 262,102 | 120.25M |
| 288 | ENOV | Enovis Corporation | 1.57B | -2.51% | 1,106,431 | 2.31B |
| 289 | OMCL | Omnicell, Inc. | 1.56B | -4.06% | 482,280 | 1.24B |
| 290 | ALVO | Alvotech | 1.56B | -0.79% | 1,515,215 | 492.31M |
| 291 | NRIX | Nurix Therapeutics, Inc. | 1.56B | -3.33% | 2,225,316 | 701.94M |
| 292 | TDOC | Teladoc Health, Inc. | 1.55B | -2.41% | 4,764,027 | 2.47B |
| 293 | PGEN | Precigen, Inc. | 1.54B | -0.23% | 4,373,030 | 156.94M |
| 294 | BFLY | Butterfly Network, Inc. | 1.54B | 0.70% | 4,300,721 | 123.26M |
| 295 | BRVE | Braveheart Bio, Inc. | 1.53B | -3.64% | 971,320 | - |
| 296 | WWB | Windward Bio Group AG | 1.50B | -14.25% | 246,282 | - |
| 297 | ANIP | ANI Pharmaceuticals, Inc. | 1.48B | -1.27% | 759,767 | 1.04B |
| 298 | KRSA | Korsana Biosciences, Inc. | 1.48B | -0.55% | 202,257 | - |
| 299 | ADRX | ADARx Pharmaceuticals, Inc. | 1.48B | -1.29% | 696,893 | 6.13M |
| 300 | AMN | AMN Healthcare Services, Inc. | 1.47B | -3.88% | 494,161 | 3.52B |
| 301 | URGN | UroGen Pharma Ltd. | 1.47B | 6.30% | 2,777,524 | 250.25M |
| 302 | PCRX | Pacira BioSciences, Inc. | 1.46B | 0.00% | - | 743.30M |
| 303 | QURE | uniQure N.V. | 1.46B | -5.03% | 1,215,062 | 20.17M |
| 304 | USPH | U.S. Physical Therapy, Inc. | 1.45B | -2.22% | 300,495 | 829.86M |
| 305 | CNMD | CONMED Corporation | 1.44B | -1.95% | 294,098 | 1.37B |
| 306 | IMCR | Immunocore Holdings plc | 1.44B | -3.70% | 419,034 | 429.30M |
| 307 | PAHC | Phibro Animal Health Corporation | 1.42B | -0.29% | 130,090 | 1.54B |
| 308 | WGS | GeneDx Holdings Corp. | 1.42B | -7.31% | 1,991,876 | 460.78M |
| 309 | RAPP | Rapport Therapeutics, Inc. | 1.41B | -4.27% | 526,323 | 20.00M |
| 310 | LMRI | Lumexa Imaging Holdings, Inc. | 1.41B | -1.08% | 278,129 | 1.06B |
| 311 | DMRA | Damora Therapeutics, Inc. | 1.40B | 0.29% | 396,003 | - |
| 312 | NBTX | Nanobiotix S.A. | 1.38B | -3.82% | 107,029 | 13.15M |
| 313 | NUVB | Nuvation Bio Inc. | 1.38B | 1.56% | 5,758,369 | 201.73M |
| 314 | NTLA | Intellia Therapeutics, Inc. | 1.37B | -0.81% | 7,617,398 | 52.89M |
| 315 | PRCT | PROCEPT BioRobotics Corporation | 1.37B | 1.02% | 1,335,441 | 352.31M |
| 316 | ANAB | AnaptysBio, Inc. | 1.36B | -0.26% | 598,493 | 60.04M |
| 317 | TYRA | Tyra Biosciences, Inc. | 1.35B | -0.86% | 690,595 | - |
| 318 | OCUL | Ocular Therapeutix, Inc. | 1.32B | 0.17% | 6,296,705 | 50.38M |
| 319 | NVAX | Novavax, Inc. | 1.31B | -1.24% | 3,550,387 | 411.65M |
| 320 | ABSI | Absci Corporation | 1.31B | 1.34% | 4,699,470 | 1.49M |
| 321 | MNKD | MannKind Corporation | 1.31B | 2.91% | 3,446,800 | 413.37M |
| 322 | LBRX | LB Pharmaceuticals Inc | 1.30B | -6.26% | 396,095 | - |
| 323 | TSHA | Taysha Gene Therapies, Inc. | 1.30B | -1.48% | 1,987,081 | 5.49M |
| 324 | NVCR | NovoCure Limited | 1.30B | -1.42% | 1,442,883 | 725.39M |
| 325 | GPCR | Structure Therapeutics Inc. | 1.30B | -2.15% | 583,686 | - |
| 326 | INVA | Innoviva, Inc. | 1.30B | -1.03% | 989,411 | 438.32M |
| 327 | INNV | InnovAge Holding Corp. | 1.29B | -1.67% | 291,170 | 1.02B |
| 328 | STAA | STAAR Surgical Company | 1.28B | -1.73% | 420,407 | 328.27M |
| 329 | PNTG | The Pennant Group, Inc. | 1.28B | -1.43% | 416,858 | 1.17B |
| 330 | MLYS | Mineralys Therapeutics, Inc. | 1.28B | -0.34% | 995,185 | - |
| 331 | GENB | Generate Biomedicines, Inc. | 1.27B | -6.20% | 870,693 | 21.07M |
| 332 | GHRS | GH Research PLC | 1.25B | -2.56% | 324,434 | - |
| 333 | AVLN | Avalyn Pharma Inc. | 1.24B | -6.18% | 453,013 | - |
| 334 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.24B | -0.24% | 409,726 | 745.79M |
| 335 | KARD | Kardigan, Inc. | 1.23B | 2.65% | 356,748 | - |
| 336 | SLN | Silence Therapeutics plc | 1.23B | 0.00% | 1,211,335 | 456.00K |
| 337 | NKTR | Nektar Therapeutics | 1.23B | -1.45% | 731,152 | 52.19M |
| 338 | SVRA | Savara Inc. | 1.21B | 0.34% | 3,844,092 | - |
| 339 | OPK | OPKO Health, Inc. | 1.20B | 0.00% | 3,028,836 | 654.10M |
| 340 | NUTX | Nutex Health Inc. | 1.20B | 2.83% | 175,126 | 796.53M |
| 341 | TNDM | Tandem Diabetes Care, Inc. | 1.19B | -7.68% | 2,230,419 | 1.08B |
| 342 | GDRX | GoodRx Holdings, Inc. | 1.18B | -1.14% | 1,400,580 | 785.23M |
| 343 | CRON | Cronos Group Inc. | 1.18B | -2.45% | 837,035 | 206.20M |
| 344 | AAPG | Ascentage Pharma Group International | 1.16B | -1.13% | 3,063 | 94.61M |
| 345 | CMPS | COMPASS Pathways plc | 1.13B | -3.51% | 2,696,719 | - |
| 346 | VOR | Vor Biopharma Inc. | 1.12B | -4.16% | 826,258 | - |
| 347 | DRTS | Alpha Tau Medical Ltd. | 1.12B | 1.00% | 1,088,693 | - |
| 348 | HROW | Harrow, Inc. | 1.11B | 1.48% | 453,462 | 303.25M |
| 349 | INBX | Inhibrx Biosciences, Inc. | 1.10B | -4.48% | 300,270 | 2.00M |
| 350 | ATEC | Alphatec Holdings, Inc. | 1.08B | 2.36% | 3,135,931 | 839.72M |
| 351 | IRMD | IRADIMED CORPORATION | 1.07B | -1.64% | 85,462 | 89.34M |
| 352 | JBIO | Jade Biosciences, Inc. | 1.07B | 0.39% | 2,078,548 | - |
| 353 | AHG | Akso Health Group | 1.06B | -6.77% | 2,487 | 13.83M |
| 354 | FRNM | Freenome, Inc. | 1.06B | -2.68% | 528,508 | 217.86M |
| 355 | IART | Integra LifeSciences Holdings Corporation | 1.05B | -3.08% | 1,237,674 | 1.66B |
| 356 | SGP | SpyGlass Pharma, Inc. | 1.05B | -2.50% | 88,109 | - |
| 357 | SIBN | SI-BONE, Inc. | 1.04B | -1.07% | 875,919 | 220.65M |
| 358 | CSTL | Castle Biosciences, Inc. | 1.02B | 0.70% | 339,202 | 377.13M |
| 359 | GMRS | GMR Solutions Inc. | 1.01B | -4.52% | 1,063,874 | 5.97B |
| 360 | CBLL | CeriBell, Inc. | 1.01B | -1.70% | 428,156 | 108.72M |
| 361 | OMER | Omeros Corporation | 1.01B | -16.55% | 5,345,411 | 74.36M |
| 362 | AHCO | AdaptHealth Corp. | 1.01B | -2.59% | 1,805,642 | 3.44B |
| 363 | ANRO | Alto Neuroscience, Inc. | 999.16M | -8.15% | 498,677 | - |
| 364 | SPTX | Seaport Therapeutics, Inc. | 972.65M | -4.97% | 278,256 | - |
| 365 | MLTX | MoonLake Immunotherapeutics | 957.45M | -4.09% | 1,185,637 | - |
| 366 | VSTM | Verastem, Inc. | 933.77M | -3.77% | 2,874,722 | 100.30M |
| 367 | ODTX | Odyssey Therapeutics, Inc. | 928.62M | 0.05% | 301,617 | 99.00K |
| 368 | LTGO | Latigo Biotherapeutics, Inc. | 912.28M | 9.21% | 661,641 | - |
| 369 | AKTS | Aktis Oncology, Inc. | 910.06M | 0.93% | 473,264 | 12.39M |
| 370 | BVS | Bioventus Inc. | 893.17M | 1.34% | 562,599 | 585.64M |
| 371 | AORT | Artivion, Inc. | 891.39M | -1.08% | 561,741 | 481.88M |
| 372 | PHAR | Pharming Group N.V. | 874.40M | -4.21% | 8,541 | 386.75M |
| 373 | OMDA | Omada Health, Inc. | 873.49M | -2.83% | 986,781 | 333.04M |
| 374 | CTY | City Therapeutics, Inc. | 870.74M | 3.06% | 321,271 | 14.34M |
| 375 | IMTX | Immatics N.V. | 859.78M | 1.94% | 3,164,203 | 49.33M |
| 376 | CRVS | Corvus Pharmaceuticals, Inc. | 857.87M | -4.06% | 925,976 | - |
| 377 | HSTM | HealthStream, Inc. | 846.39M | -0.18% | 202,819 | 327.95M |
| 378 | BBTX | Bambusa Therapeutics, Inc. | 832.91M | 2.32% | 198,256 | - |
| 379 | ORIC | ORIC Pharmaceuticals, Inc. | 831.45M | 6.38% | 2,000,023 | - |
| 380 | SNDX | Syndax Pharmaceuticals, Inc. | 828.26M | 0.77% | 2,597,943 | 289.68M |
| 381 | MGTX | MeiraGTx Holdings plc | 826.80M | -3.20% | 825,036 | 401.91M |
| 382 | KIDS | OrthoPediatrics Corp. | 820.13M | -0.29% | 172,045 | 264.14M |
| 383 | RIGL | Rigel Pharmaceuticals, Inc. | 808.18M | -1.85% | 242,199 | 288.21M |
| 384 | IRWD | Ironwood Pharmaceuticals, Inc. | 806.23M | 0.41% | 2,824,898 | 400.30M |
| 385 | BBNX | Beta Bionics, Inc. | 800.28M | -3.22% | 1,075,552 | 127.27M |
| 386 | ARDX | Ardelyx, Inc. | 799.36M | 3.58% | 4,394,331 | 468.22M |
| 387 | COLL | Collegium Pharmaceutical, Inc. | 793.98M | 0.47% | 365,254 | 815.19M |
| 388 | LXRX | Lexicon Pharmaceuticals, Inc. | 792.52M | 1.71% | 2,416,624 | 38.54M |
| 389 | PHR | Phreesia, Inc. | 779.61M | -2.03% | 654,221 | 507.79M |
| 390 | GLUE | Monte Rosa Therapeutics, Inc. | 775.03M | -0.98% | 1,176,564 | 70.33M |
| 391 | VREX | Varex Imaging Corporation | 762.88M | -0.17% | 1,241,308 | 865.00M |
| 392 | IVA | Inventiva S.A. | 752.20M | -3.01% | 2,046,877 | 2.81M |
| 393 | OBX | Obsidian Therapeutics, Inc. | 745.60M | -2.35% | 282,022 | - |
| 394 | CTKB | Cytek Biosciences, Inc. | 745.47M | 1.24% | 1,109,243 | 207.65M |
| 395 | AURA | Aura Biosciences, Inc. | 744.13M | -0.97% | 627,642 | - |
| 396 | INMD | InMode Ltd. | 742.65M | -1.75% | 589,936 | 373.60M |
| 397 | APMD | Apnimed, Inc. | 741.03M | 9.34% | 395,528 | 108.80M |
| 398 | OABI | OmniAb, Inc. | 736.59M | 3.27% | 1,263,954 | 40.21M |
| 399 | SGMT | Sagimet Biosciences Inc. | 702.97M | -2.76% | 843,623 | - |
| 400 | SLDB | Solid Biosciences Inc. | 695.33M | -3.86% | 1,133,949 | - |
| 401 | KURA | Kura Oncology, Inc. | 688.17M | 5.64% | 3,140,555 | 79.31M |
| 402 | PRME | Prime Medicine, Inc. | 685.24M | -8.35% | 4,503,951 | 7.06M |
| 403 | ATTO | Attovia Therapeutics, Inc. | 678.38M | 0.88% | 292,410 | 1.44M |
| 404 | QDEL | QuidelOrtho Corporation | 677.21M | -3.33% | 7,719,584 | 2.59B |
| 405 | FLGT | Fulgent Genetics, Inc. | 676.40M | 0.54% | 277,141 | 330.28M |
| 406 | IAM | Iambic Therapeutics, Inc. | 674.04M | 20.00% | 489,266 | 18.25M |
| 407 | DCTH | Delcath Systems, Inc. | 673.84M | -2.52% | 532,489 | 109.96M |
| 408 | QUIT | Achieve Life Sciences, Inc. | 673.41M | 0.99% | 1,097,814 | - |
| 409 | ANNX | Annexon, Inc. | 661.95M | -2.80% | 2,880,262 | - |
| 410 | NVCT | Nuvectis Pharma, Inc. | 660.27M | 0.47% | 181,015 | - |
| 411 | JANX | Janux Therapeutics, Inc. | 655.27M | -1.92% | 735,262 | 23.29M |
| 412 | GERN | Geron Corporation | 644.24M | 6.17% | 13,264,556 | 217.52M |
| 413 | SOPH | SOPHiA GENETICS SA | 638.15M | 0.13% | 469,515 | 90.97M |
| 414 | BCAX | Bicara Therapeutics Inc. | 637.32M | -1.54% | 918,174 | - |
| 415 | OLMA | Olema Oncology, Inc. | 632.52M | -1.90% | 1,266,550 | - |
| 416 | DSGN | Design Therapeutics, Inc. | 630.12M | -0.81% | 294,392 | - |
| 417 | ALMS | Alumis Inc. | 628.33M | -5.84% | 1,861,053 | 7.24M |
| 418 | DBVT | DBV Technologies S.A. | 624.05M | -2.73% | 165,385 | 3.74M |
| 419 | ABUS | Arbutus Biopharma Corporation | 620.84M | 0.25% | 2,215,047 | 181.49M |
| 420 | ANL | Adlai Nortye Group Ltd. | 610.49M | -5.48% | 291,794 | 18.06M |
| 421 | FDMT | 4D Molecular Therapeutics, Inc. | 608.33M | -4.43% | 814,094 | 96.06M |
| 422 | IMMX | Immix Biopharma, Inc. | 603.45M | -3.74% | 994,013 | - |
| 423 | CGEM | Cullinan Therapeutics, Inc. | 602.14M | -2.37% | 1,626,165 | - |
| 424 | TCMD | Tactile Systems Technology, Inc. | 583.56M | -1.21% | 222,320 | 356.42M |
| 425 | SGHT | Sight Sciences, Inc. | 583.02M | -0.94% | 271,335 | 88.40M |
| 426 | CLYM | Climb Bio, Inc. | 574.46M | -1.61% | 593,760 | - |
| 427 | SRZN | Surrozen, Inc. | 571.47M | -7.24% | 218,221 | 10.53M |
| 428 | PACB | Pacific Biosciences of California, Inc. | 569.53M | -1.09% | 13,344,811 | 161.39M |
| 429 | SANA | Sana Biotechnology, Inc. | 563.31M | 0.00% | 2,632,567 | - |
| 430 | WVE | Wave Life Sciences, Inc. | 560.13M | -1.05% | 2,785,394 | 70.92M |
| 431 | ZVRA | Zevra Therapeutics, Inc. | 559.34M | 1.62% | 836,754 | 147.76M |
| 432 | CBIO | Crescent Biopharma, Inc. | 558.13M | -3.41% | 214,585 | 15.00M |
| 433 | SENS | Senseonics Holdings, Inc. | 556.57M | -6.79% | 1,707,238 | 60.01M |
| 434 | AVBP | ArriVent BioPharma, Inc. | 552.92M | -7.53% | 863,857 | 5.00M |
| 435 | NRC | NRC Health | 549.32M | -1.69% | 79,758 | 143.79M |
| 436 | OBIO | Orchestra BioMed Holdings, Inc. | 548.57M | -2.11% | 552,138 | 31.21M |
| 437 | DNA | Ginkgo Bioworks Holdings, Inc. | 539.28M | -2.12% | 2,485,570 | 130.75M |
| 438 | EVO | Evotec SE | 538.46M | -5.13% | 63,614 | 815.72M |
| 439 | ACRS | Aclaris Therapeutics, Inc. | 536.11M | -6.24% | 3,125,100 | 6.40M |
| 440 | VALN | Valneva SE | 534.63M | -1.50% | 5,982 | 163.30M |
| 441 | MYGN | Myriad Genetics, Inc. | 531.41M | -0.54% | 1,119,064 | 803.60M |
| 442 | HELP | Helus Pharma Inc. | 526.03M | -6.13% | 3,029,376 | - |
| 443 | ETRA | Electra Therapeutics, Inc. | 524.10M | 0.48% | 332,203 | - |
| 444 | EVH | Evolent Health, Inc. | 522.55M | -4.35% | 1,542,012 | 2.34B |
| 445 | ENTX | Entera Bio Ltd. | 522.41M | -0.66% | 187,392 | 42.00K |
| 446 | AVR | Anteris Technologies Global Corp. | 518.67M | -6.67% | 1,179,431 | 2.33M |
| 447 | INDP | Indaptus Therapeutics, Inc. | 509.89M | -3.77% | 278,499 | - |
| 448 | RCEL | AVITA Medical, Inc. | 499.72M | 3.61% | 471,656 | 84.68M |
| 449 | GYRE | Gyre Therapeutics, Inc. | 499.10M | 3.87% | 215,958 | 110.06M |
| 450 | CAPR | Capricor Therapeutics, Inc. | 488.98M | 1.33% | 4,693,637 | 11.13M |
| 451 | CARL | Carlsmed, Inc. | 486.15M | 2.25% | 292,413 | 71.78M |
| 452 | ANGO | AngioDynamics, Inc. | 483.21M | -2.46% | 304,464 | 325.38M |
| 453 | MNPR | Monopar Therapeutics Inc. | 481.56M | -1.26% | 126,675 | - |
| 454 | TKNO | Alpha Teknova, Inc. | 481.21M | -1.54% | 171,773 | 45.95M |
| 455 | BLSM | BlossomHill Therapeutics, Inc. | 480.91M | 10.84% | 390,259 | - |
| 456 | FENC | Fennec Pharmaceuticals Inc. | 479.44M | 6.43% | 908,894 | 66.37M |
| 457 | RGNX | REGENXBIO Inc. | 478.73M | -1.09% | 963,090 | 153.91M |
| 458 | NGNE | Neurogene Inc. | 478.19M | -0.86% | 278,145 | 925.00K |
| 459 | KMDA | Kamada Ltd. | 468.78M | 0.62% | 74,669 | 196.87M |
| 460 | SRTA | Strata Critical Medical, Inc. | 468.04M | -3.32% | 1,035,637 | 280.76M |
| 461 | STTK | Shattuck Labs, Inc. | 467.46M | -1.50% | 785,681 | 1.00M |
| 462 | AQST | Aquestive Therapeutics, Inc. | 465.04M | -1.60% | 2,117,665 | 48.84M |
| 463 | MDXG | MiMedx Group, Inc. | 464.04M | 0.00% | 2,043,451 | 303.73M |
| 464 | OCS | Oculis Holding AG | 463.61M | -1.57% | 239,990 | 1.12M |
| 465 | ASMB | Assembly Biosciences, Inc. | 460.74M | 5.68% | 326,483 | 67.01M |
| 466 | DMAC | DiaMedica Therapeutics Inc. | 452.16M | 0.60% | 295,262 | - |
| 467 | ARVN | Arvinas, Inc. | 446.61M | 0.74% | 1,527,978 | 275.30M |
| 468 | EOLS | Evolus, Inc. | 442.80M | 0.90% | 670,703 | 325.47M |
| 469 | PHAT | Phathom Pharmaceuticals, Inc. | 436.87M | -6.46% | 1,060,659 | 274.88M |
| 470 | EPRX | Eupraxia Pharmaceuticals Inc. | 436.08M | -9.81% | 1,635,039 | - |
| 471 | SI | Shoulder Innovations, Inc. | 430.17M | 0.54% | 147,146 | 64.49M |
| 472 | PRTA | Prothena Corporation plc | 424.15M | 3.64% | 596,417 | 52.74M |
| 473 | CADL | Candel Therapeutics, Inc. | 423.61M | -7.06% | 1,805,032 | - |
| 474 | CTMX | CytomX Therapeutics, Inc. | 422.93M | -2.27% | 2,147,515 | 14.03M |
| 475 | RZLT | Rezolute, Inc. | 421.19M | 12.15% | 2,889,896 | - |
| 476 | MOBI | Mobia Medical, Inc. | 420.26M | -4.11% | 104,009 | 51.89M |
| 477 | OVID | Ovid Therapeutics Inc. | 418.98M | -7.50% | 2,432,191 | 1.45M |
| 478 | AVTX | Avalo Therapeutics, Inc. | 412.28M | -3.26% | 3,133,758 | 59.00K |
| 479 | TECX | Tectonic Therapeutic, Inc. | 392.55M | -4.29% | 144,259 | - |
| 480 | CTEV | Claritev Corporation | 391.87M | -8.16% | 210,784 | 1.02B |
| 481 | IRD | Opus Genetics, Inc. | 391.45M | 0.25% | 730,826 | 7.91M |
| 482 | MASS | 908 Devices Inc. | 390.46M | 2.18% | 313,005 | 65.79M |
| 483 | CERS | Cerus Corporation | 383.71M | 2.15% | 4,638,314 | 226.57M |
| 484 | ALEC | Alector, Inc. | 381.13M | -0.39% | 1,269,374 | 173.47M |
| 485 | CTNM | Contineum Therapeutics, Inc. | 374.99M | -1.24% | 294,108 | - |
| 486 | BWAY | BrainsWay Ltd. | 372.71M | -2.98% | 153,884 | 60.70M |
| 487 | CRMD | CorMedix Inc. | 371.44M | -3.11% | 1,987,769 | 412.49M |
| 488 | PBYI | Puma Biotechnology, Inc. | 369.13M | -2.72% | 593,814 | 231.83M |
| 489 | SPRY | ARS Pharmaceuticals, Inc. | 366.93M | 1.67% | 1,191,844 | 122.14M |
| 490 | MPLT | MapLight Therapeutics, Inc. | 365.13M | -4.78% | 547,766 | - |
| 491 | SLBT | SL Science Holding Limited | 362.18M | -11.73% | 60,348 | 3.27M |
| 492 | CV | CapsoVision, Inc. | 356.50M | 2.78% | 158,145 | 13.92M |
| 493 | AUNA | Auna S.A. | 353.04M | 3.02% | 195,747 | 1.42B |
| 494 | ASPE | Aspen Neuroscience, Inc. | 348.94M | -1.88% | 256,848 | - |
| 495 | EMBC | Embecta Corp. | 348.46M | -1.60% | 933,859 | 1.02B |
| 496 | STLN | Starling Oncology, Inc. | 346.77M | -3.95% | 4,010,843 | 620.45M |
| 497 | TLRY | Tilray Brands, Inc. | 344.66M | 0.43% | 3,959,355 | 963.10M |
| 498 | VMD | Viemed Healthcare, Inc. | 343.69M | -0.87% | 168,390 | 310.37M |
| 499 | PRLD | Prelude Therapeutics Incorporated | 342.83M | -2.64% | 422,334 | 21.57M |
| 500 | LYEL | Lyell Immunopharma, Inc. | 336.08M | -6.69% | 175,807 | 15.00K |